Search Results 141-150 of 18656 for Parkinson's disease
Dr. Savica collaborates with other investigators to improve diagnosis and treatment of early-onset Parkinson's disease and related disorders.
This Mayo Clinic Medical Edge Weekend episode is a "best of" with Dr. Eric Ahlskog talking about Parkinson's Disease. ... To watch a video of Dr. Ahlskog talking ...
Does dual hemispheric stimulation of the subthalamic nucleus (STN) and fornix/hypothalamus potentially improve cognitive function in patients with Parkinsons ...
Rivastigmine is used to treat mild to moderate dementia (memory loss and mental changes) associated with Alzheimer's disease or Parkinson's disease.
View faculty and staff of Mayo Clinic's Neurobiology of Parkinson's Disease Lab and Related Disorders Lab led by Pam J. McLean, Ph.D.
See faculty and staff of the Early-Onset Parkinson's Disease and Synucleinopathies Lab at Mayo Clinic led by Rodolfo Savica, M.D., Ph.D.
The purpose of this study is to compare treadmill walking and over ground walking gait characteristics in people diagnosed with Parkinson's disease.
There are only 10 Udall centers across the country investigating Parkinson's disease and other Parkinsonian disorders. In the United States, about 50,000 new ...
Sometimes deep brain stimulation may be an option to treat movement disorders such as essential tremor or Parkinson's disease. Request an appointment ...
Mayo Clinic's Translational Cell Biology of Parkinson's Disease Lab led by Wolfdieter Springer, Ph.D., is identifying novel mitophagy regulators and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.